Global Cholera Vaccines Market Is Driven By Increasing Awareness And Global Outbreaks

Author : Sneha Biswal | Published On : 08 Apr 2024

Global Cholera Vaccines market overview: Cholera vaccines are given orally to aid in preventing the spread of the cholera virus. The vaccine contains live, weakened strains of the Vibrio cholerae bacteria, which causes cholera. Once administered, the vaccine strains multiply in the intestines and induce protection without causing illness. Cholera often strikes in areas with poor sanitation and limited access to clean water. It causes acute watery diarrhea and can kill within hours if untreated.

Key Takeaways

Key players operating in the Global Cholera Vaccines are Sanofi, Biovac.co.za., EMERGENT, Celldex Therapeutics, Valneva SE, Hilleman Laboratories, Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital), PaxVax, Inc., Astellas Pharma Inc., and EUBIOLOGICS CO., LTD. Sanofi's oral cholera vaccine Dukoral is the leading vaccine in many regions. Biovac has an oral multi-strain vaccine approved for use in Africa and South America.

The growing demand for Cholera Vaccines Market Growth is driven by increasing global outbreaks of the disease. Between 2010-2019, over 1.3 million cases of cholera were reported to WHO from 58 countries. Recurring outbreaks across Africa, Asia, and Haiti underscore the ongoing need for vaccination campaigns in vulnerable areas.

Increasing numbers of manufacturers are expanding the geographic availability and supply of effective cholera vaccines. Valneva, EpiVax, and others are working to develop lower-cost second-generation vaccines that provide broad coverage of cholera strains and longer-lasting immunity. Expanding production capacity in emerging markets will help control future outbreaks.

Market drivers

Increasing global awareness about cholera prevention is driving demand for vaccination. International organizations like WHO recommend vaccination for high-risk populations in endemic areas and during outbreaks. Enhanced surveillance systems now enable more timely identification and response to cholera cases worldwide. Government stockpiling of oral cholera vaccines also facilitates rapid deployment when outbreaks emerge. Continued education efforts will be crucial to sustaining vaccination programs over the long run.

Impact of Geopolitical Situation on Global Cholera Vaccines Market Growth

The ongoing geopolitical conflicts and instability in various regions have negatively impacted the growth of the global cholera vaccines market. The outbreak of war and civil unrest in some countries in Asia Pacific, Middle East and Africa have disrupted vaccination programs and hindered people's access to healthcare facilities. This has increased the risks of cholera outbreaks in these insecure regions. For instance, the political conflicts in Yemen have exacerbated the worst cholera outbreak in recent history. Similarly, instability in countries like South Sudan, Somalia and Democratic Republic of Congo poses challenges to effective immunization against cholera.

Rising global refugee crisis due to wars and violence has also increased the vulnerabilities. Overcrowded and unsanitary living conditions in refugee camps often lack basic water and sanitation infrastructure, increasing the chances of cholera transmission. To counter these challenges, humanitarian organizations and governments need to devise special vaccination strategies and improve access to oral cholera vaccines in high-risk communities impacted by conflicts and displacement. Regional and international collaborations also need to be strengthened to ensure uninterrupted vaccine supply chains.

Geographical Regions with Highest Market Concentration

The global cholera vaccines market is currently concentrated highly in Asia Pacific region in terms of value. Countries like India, Philippines and Indonesia have witnessed highest burden of cholera diseases historically and annual outbreaks are common. These developing nations account for nearly 65% of total market share due to widespread adoption of oral vaccines in their national immunization programs. Large population densities coupled with inadequate sanitation especially in rural areas continue to make the region most vulnerable to this deadly infection. Mass vaccination drives are regularly carried out by governments and philanthropies to control the morbidities in the region.

Fastest Growing Region

Africa region is expected to experience fastest growth in the cholera vaccines market during the forecast period. While countries like DRC and South Sudan already have highest disease prevalence, the market is still at a nascent stage. Initiatives by WHO and GAVI to stockpile vaccines for emergency responses and introduce them in some new nations are likely to significantly drive the uptake. Growing focus on strengthening immunization as part of global strategy to tackle antimicrobial resistance will further aid penetration. Expanding access to oral vaccines can play a pivotal role in reducing cholera mortality across African communities heavily impacted by conflicts, poverty and unsafe water sources.

Get more insights on Cholera Vaccines Market